Pharma is the industry engaged in researching, developing, manufacturing and distributing drugs including prescription drugs and OTC drugs for human or veterinary use. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may only be sold to consumers possessing a valid prescription.

The report focuses on the Pharma and OTC market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Pharma and OTC market.

Major Players in the Pharma and OTC market are:

PGT Healthcare

Takeda

Boehringer Ingelheim

Teva Pharmaceutical

Novartis International AG

Johnson & Johnson

Endo

Abbott

Bayer

GlaxoSmithKline PLC

Daiichi-Sankyo

Sanofi S.A.

Pfizer

On the basis of types, the Pharma and OTC market is primarily split into:

Analgesics

Dermatological Agents

Cough, Cold & Allergy Medicine

Digestive Remedies

On the basis of applications, the market covers:

Infant

Kid

Adult

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Pharma and OTC Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029

Chapter 1 Pharma and OTC Market Overview
1.1 Product Overview and Scope of Pharma and OTC
1.2 Pharma and OTC Market Segmentation by Type
1.2.1 Global Production Market Share of Pharma and OTC by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Pharma and OTC Market Segmentation by Application
1.3.1 Pharma and OTC Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Pharma and OTC Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Pharma and OTC (2014-2029)

Chapter 2 Global Economic Impact on Pharma and OTC Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Pharma and OTC Market Competition by Manufacturers
3.1 Global Pharma and OTC Production and Share by Manufacturers (2020 and 2022)
3.2 Global Pharma and OTC Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Pharma and OTC Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Pharma and OTC Manufacturing Base Distribution, Production Area and Product Type
3.5 Pharma and OTC Market Competitive Situation and Trends
3.5.1 Pharma and OTC Market Concentration Rate
3.5.2 Pharma and OTC Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Pharma and OTC Production, Revenue (Value) by Region (2014-2022)
4.1 Global Pharma and OTC Production by Region (2014-2022)
4.2 Global Pharma and OTC Production Market Share by Region (2014-2022)
4.3 Global Pharma and OTC Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Pharma and OTC Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Pharma and OTC Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Pharma and OTC Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Pharma and OTC Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Pharma and OTC Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Pharma and OTC Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Pharma and OTC Production, Revenue, Price and Gross Margin (2014-2022)

Chapter 5 Global Pharma and OTC Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Pharma and OTC Consumption by Regions (2014-2022)
5.2 North America Pharma and OTC Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Pharma and OTC Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Pharma and OTC Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Pharma and OTC Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Pharma and OTC Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Pharma and OTC Production, Consumption, Export, Import by Regions (2014-2022)

Chapter 6 Global Pharma and OTC Production, Revenue (Value), Price Trend by Type
6.1 Global Pharma and OTC Production and Market Share by Type (2014-2022)
6.2 Global Pharma and OTC Revenue and Market Share by Type (2014-2022)
6.3 Global Pharma and OTC Price by Type (2014-2022)
6.4 Global Pharma and OTC Production Growth by Type (2014-2022)

Chapter 7 Global Pharma and OTC Market Analysis by Application
7.1 Global Pharma and OTC Consumption and Market Share by Application (2014-2022)
7.2 Global Pharma and OTC Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Pharma and OTC Manufacturing Cost Analysis
8.1 Pharma and OTC Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pharma and OTC

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pharma and OTC Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pharma and OTC Major Manufacturers in 2020
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global Pharma and OTC Market Forecast (2022-2029)
12.1 Global Pharma and OTC Production, Revenue Forecast (2022-2029)
12.2 Global Pharma and OTC Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Pharma and OTC Production Forecast by Type (2022-2029)
12.4 Global Pharma and OTC Consumption Forecast by Application (2022-2029)
12.5 Pharma and OTC Price Forecast (2022-2029)

Chapter 13 Appendix